Advertisement

We need your help now

Support from readers like you keeps The Journal open.

You are visiting us because we have something you value. Independent, unbiased news that tells the truth. Advertising revenue goes some way to support our mission, but this year it has not been enough.

If you've seen value in our reporting, please contribute what you can, so we can continue to produce accurate and meaningful journalism. For everyone who needs it.

PA

Vaccine hesitancy linked to lack of knowledge on benefits of jab, study suggests

People who are less likely to follow news coverage about Covid-19 are more likely to be vaccine hesitant, the research found.

PEOPLE WHO ARE less likely to follow news coverage about Covid-19 are more likely to be vaccine hesitant, a study suggests.

A study by the Economic and Social Research Institute’s (ESRI) Behavioural Research Unit found a link between a reluctance to take the vaccine and a lack of knowledge and awareness of its benefits.

The Department of Health-funded study conducted a knowledge test and survey of attitudes among a nationally representative scale sample of the Irish population in January 2021.

It found that the less people followed news coverage about Covid-19, the less likely they were to want to take the vaccine.

Dr Deirdre Robertson, lead researcher on the study, said: “These results suggest that some people who are unsure about taking the Covid-19 vaccine may not know enough about it.

“The results suggest that providing factual information about how the vaccine was developed and tested, and the real-world effectiveness of the vaccines at preventing illness, may bridge this gap in knowledge.”

Participants in the study completed a series of tasks designed to find out what they think about the vaccine, how much they know about it, what they see as the greatest risks and benefits, and whether they plan to take it.

A multiple-choice quiz asked them questions on what they knew about the effectiveness of the jab, the development process, possible side effects and cost.

The minority of participants planning not to take the vaccine, or who were unsure, scored substantially more poorly on the quiz than the majority planning to take it.

Those planning to take the vaccine got an average score of 67%, compared with 50% for those who were unsure and just 37% for those planning not to take it.

Participants were also asked to list their thoughts about the risks and benefits of the vaccine.

Most people listed at least one risk, but there was a big difference in the listing of benefits.

Only 5% of those planning not to take the vaccine and around 50% of those who were unsure listed any benefit at all.

This compared with 91% of people planning to take it.

Professor Pete Lunn, head of the Behavioural Research Unit, said: “Since we collected this data, the numbers wanting to take the vaccine have risen steadily, perhaps reflecting improved knowledge and recognition of the benefits that the vaccine brings.

“But the study shows that a minority of the population do not follow the news about Covid-19 and may take longer to realise how effective and safe the vaccines are.”

The working paper, A Lack of Perceived Benefits and a Gap in Knowledge Distinguish the Vaccine Hesitant from Vaccine Accepting during the Covid-19 Pandemic, can be read here.

Readers like you are keeping these stories free for everyone...
A mix of advertising and supporting contributions helps keep paywalls away from valuable information like this article. Over 5,000 readers like you have already stepped up and support us with a monthly payment or a once-off donation.

View 77 comments
Close
77 Comments
This is YOUR comments community. Stay civil, stay constructive, stay on topic. Please familiarise yourself with our comments policy here before taking part.
Leave a Comment
    Submit a report
    Please help us understand how this comment violates our community guidelines.
    Thank you for the feedback
    Your feedback has been sent to our team for review.

    Leave a commentcancel

     
    JournalTv
    News in 60 seconds